by John Conrad | Sep 27, 2019 | 2019 Fed Issue, Policy News
On Sept. 19, House Speaker Nancy Pelosi (D-San Francisco) unveiled legislation in the form of the Lower Drug Costs Now Act (H.R. 3) Illinois is home to over 45,000 researchers, doctors, lawyers and business women and men in the biopharma industry who have an...
by John Conrad | Sep 26, 2019 | Policy News
This Oped was originally published in Crain’s Chicago Business on September 6, 2019 John Pletz’s article (“Will these startups help biotech take root in Chicago?” Aug. 9) highlights a shift in the Illinois biotech community and underscores the need...
by John Conrad | Sep 25, 2019 | iBIO News, Policy News
iBIO along with The Advanced Medical Technology Association (AdvaMed), the Medical Device Manufacturers Association (MDMA), the Medical Imaging & Technology Alliance (MITA) and a broad coalition of medical innovators, physician inventors, patient groups, and...
by John Conrad | Sep 2, 2019 | Policy News
Governor J.B. Pritzker signed HB 465 regulating Pharmacy Benefit Managers (PBMs), which are businesses that negotiate prices between drug manufacturers and pharmacies on behalf of insurance companies. Falling under the Illinois Department of Insurance, the new PBM...
by John Conrad | Aug 28, 2019 | iBIO News, Policy News
On August 26th Governor Pritzker signed SB 1726 which expanded Illinois Alzheimer’s Disease Advisory Committee and the Alzheimer’s Disease Research, Care and Support Fund. The bill also creates the full-time position of Dementia Coordinator within the Department of...
by John Conrad | Aug 3, 2019 | iBIO News, Policy News
On Friday, August 2nd, Governor Pritzker signed SB1591, extending Illinois R&D Tax Credit and establishes a new apprenticeship credit for business to invest in Illinois’ workforce. R&D is critical to the life sciences industry in Illinois, because innovation...
